Literature DB >> 2082126

Pharmacokinetic analysis of blood distribution of intravenously administered 153Gd-labeled Gd(DTPA)2- and 99mTc(DTPA) in rats.

P Wedeking1, S Eaton, D G Covell, S Nair, M F Tweedle, W C Eckelman.   

Abstract

Rat plasma distribution data obtained following IV administration of 99mTc(DTPA) alone or after co-administration of 99mTc(DTPA) and 153Gd-labeled Gd(DTPA)2- at 0.001, 0.1, and 1.0 mmol Gd/kg were evaluated using compartmental modeling techniques. A three-compartment open model was found to fit the data significantly better (P less than 0.01) than a two- or four-compartment open model. This model incorporates and links the plasma and urine data and includes a delay to account for the transit time through the kidneys/ureters. The two nonplasma compartments of the model were assumed to be related to rapidly and slowly equilibrating tissues. Tc(DTPA) and Gd(DTPA)2- had nearly identical pharmacokinetic profiles in plasma and the rate constants were essentially the same. No significant dose dependent pharmacokinetic differences were found for the range of Gd(DTPA)2- doses tested. Simulations of the proposed three-compartment model were used to generate concentration-time curves for each of the three compartments.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2082126     DOI: 10.1016/0730-725x(90)90133-m

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  10 in total

Review 1.  Analysis of contrast-enhanced MR images to assess renal function.

Authors:  N Michoux; J-P Vallée; A Pechère-Bertschi; X Montet; L Buehler; B E Van Beers
Journal:  MAGMA       Date:  2006-08-12       Impact factor: 2.310

Review 2.  Gadolinium-based contrast agents: why nephrologists need to be concerned.

Authors:  Katarina Leyba; Brent Wagner
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-03       Impact factor: 2.894

3.  Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis.

Authors:  Pubudu M Peiris; Partha Deb; Elizabeth Doolittle; Gilad Doron; Amy Goldberg; Priya Govender; Shruti Shah; Swetha Rao; Sarah Carbone; Thomas Cotey; Meilyn Sylvestre; Sohaj Singh; William P Schiemann; Zhenghong Lee; Efstathios Karathanasis
Journal:  J Pharm Sci       Date:  2015-06-02       Impact factor: 3.534

Review 4.  Exposure, metabolism, and toxicity of rare earths and related compounds.

Authors:  S Hirano; K T Suzuki
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

5.  A dedicated automated injection system for dynamic contrast-enhanced MRI experiments in mice.

Authors:  Jan Sedlacik; Adrianne Myers; Ralf B Loeffler; Regan F Williams; Andrew M Davidoff; Claudia M Hillenbrand
Journal:  J Magn Reson Imaging       Date:  2012-09-21       Impact factor: 4.813

6.  Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats.

Authors:  Daniel P Bradley; Jean J Tessier; Susan E Ashton; John C Waterton; Zena Wilson; Philip L Worthington; Anderson J Ryan
Journal:  Neoplasia       Date:  2007-05       Impact factor: 5.715

7.  Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas.

Authors:  L S Hu; L C Baxter; D S Pinnaduwage; T L Paine; J P Karis; B G Feuerstein; K M Schmainda; A C Dueck; J Debbins; K A Smith; P Nakaji; J M Eschbacher; S W Coons; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 3.825

8.  The interaction of gadolinium complexes with isolated rat hepatocytes.

Authors:  K Thorstensen; I Romslo
Journal:  Biometals       Date:  1995-01       Impact factor: 2.949

9.  Influence of the pharmacokinetic model on the quantification of the Gd-DTPA uptake rate in brain tumours using direct T1 measurements.

Authors:  T H Rozijn; B P van der Sanden; A Heerschap; J H Creyghton; W M Bovée
Journal:  MAGMA       Date:  1998-08       Impact factor: 2.533

10.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.

Authors:  Thomas Nielsen; Thomas Wittenborn; Michael R Horsman
Journal:  Pharmaceutics       Date:  2012-11-07       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.